Viewing Study NCT06391307



Ignite Creation Date: 2024-05-06 @ 8:28 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06391307
Status: RECRUITING
Last Update Posted: 2024-05-14
First Post: 2024-04-22

Brief Title: The Role of Mesenchymal Stem Cell and Exosome in Treating Pilonidal Sinus Disease in Children
Sponsor: Mustafa Azizoğlu
Organization: Necmi Kadıoğlu Hospital

Study Overview

Official Title: The Role of Mesenchymal Stem Cell and Exosome in Treating Pilonidal Sinus Disease in Children A Prospective Randomized Controlled Trial
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Chronic wounds that fail to heal over extended periods pose a significant financial burden on the healthcare system underscoring the urgent need to enhance clinical treatments Among the most promising approaches are stem cell-based therapies Substantial evidence suggests that mesenchymal stem cells MSCs can facilitate the healing of chronic wounds in both animal models and preclinical studies primarily through their paracrine actions The bioactive factors and cytokines secreted by MSCs can be harvested in the form of conditioned medium This medium has been processed into a lyophilized powder for clinical use Patients with chronic wounds will recruited and divided into two groups the control group will receive the commonly used fibroblast growth factor while the experimental group was treated with the lyophilized powder The study aims to assess the efficacy and safety of this Stem cell and exosome in treating chronic wounds especially pilonidal sinus
Detailed Description: Pilonidal sinus disease PSD is an infectious or inflammatory condition beneath the skin at the peak of the gluteal cleft in the sacrococcygeal area It is a chronic condition characterized by discharge infection and pain Although it can occur during adolescence it is most commonly seen in adult males leading to a focus on adult treatments in research Surgical treatment was first implemented by Anderson in 1847 Since then various surgical and medical treatment options have been explored yet there is no widely accepted standardized treatment The ideal treatment should be simple require a short hospital stay have low recurrence rates provide good cosmetic results be cost-effective cause minimal pain and allow a quick return to social life making the surgical approach contentious

Maurice and Greenwood first reported the application of liquid phenol in 1964 initially under general anesthesia later shifting to local anesthesia Due to high recurrence rates with liquid phenol Dogru and colleagues introduced the crystallized phenol CP procedure a minimally invasive method now commonly used in adults

Recent years have shown that stem cells and exosomes promote tissue healing and reduce inflammation Known for their ability to differentiate into various cell types stem cells and exosomes play critical roles in intercellular communication containing a variety of molecules Their use in surgical fields has become popular as they speed up the post-operative healing process and reduce the risk of complications Research in the literature supports that stem cells and exosomes accelerate wound healing eg Nourian Dehkordi A et al 2019

This study is based on two main premises firstly to identify the potential healing effects of stem cell and exosome applications in treating pilonidal sinus disease and secondly to comparatively assess the impact of these applications on surgical outcomes specifically regarding surgery duration complications and the healing process Comparing these two groups will help determine the value of stem cell and exosome applications in managing pilonidal sinus disease

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None